Brief: Avidity Biosciences Says Spinco To Be Led By Kathleen Gallagher As Ceo
26/10/2025 17:30
Oct 26 (Reuters) - Avidity Biosciences Inc RNA.O: AVIDITY BIOSCIENCES ENTERS INTO AGREEMENT TO BE ACQUIRED BY NOVARTIS AG AVIDITY BIOSCIENCES INC - SPINCO TO BE LED BY KATHLEEN GALLAGHER AS CEO Source text: ID:nPn3f4PYMa Further company coverage: RNA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avidity Biosciences
See all newsFactbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
Brief: Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off